Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRPR | P30550 | 10/20 | 0.58 |
| ▸ | REN | P00797 | 6/20 | 0.55 |
| ▸ | NMBR | P28336 | 2/20 | 0.49 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16716014 | 0.94 | GRPR (0.57) | GRPRRENNMBR | |
| SCHEMBL29473455 | 0.94 | GRPR (0.57) | GRPRRENNPBWR1 | |
| SCHEMBL27378954 | 0.93 | GRPR (0.69) | GRPRNMBR | |
| SCHEMBL27379518 | 0.93 | GRPR (0.69) | GRPRNMBR | |
| SCHEMBL30118088 | 0.91 | GRPR (0.62) | GRPRRENNMBR | |
| SCHEMBL17120941 | 0.91 | GRPR (0.62) | GRPRNMBR | |
| SCHEMBL30398505 | 0.90 | GRPR (0.64) | GRPRNMBR | |
| SCHEMBL29484954 | 0.90 | GRPR (0.67) | GRPRNMBR | |
| SCHEMBL29484960 | 0.90 | GRPR (0.67) | GRPRNMBR | |
| SCHEMBL31494985 | 0.89 | REN (0.53) | GRPRRENNPBWR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9035023-B2 | Bombesin analog peptide antagonist conjugates | Piramal Imaging, SA (CH) | 2015-05-19 | — | — | US | disclosed |
| US-20110097266-A1 | Bombesin Analog Peptide Antagonist Conjugates | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110097266-A1 | Bombesin Analog Peptide Antagonist Conjugates | BRS3, VIP, GRPR | GRPR 3/4885REN 1533/4885NMBR 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.